![2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE in PDB entry 1a8t, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/1a8t_entity_3_side_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>1a8t</span> contains 1 copy of <span class='highlight'>2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE</span>. Side view.")
![2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE in PDB entry 1a8t, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/1a8t_entity_3_top_image-200x200.png "Monomeric assembly 1 of PDB entry <span class='highlight'>1a8t</span> contains 1 copy of <span class='highlight'>2-BUTYL-6-HYDROXY-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-QUINAZOLIN-4-ONE</span>. Top view.")
Environment details NEW
061 250 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.